Cargando…
In silico exploration of novel protease inhibitors against coronavirus 2019 (COVID-19)
The spread of SARS-CoV-2 has affected human health globally. Hence, it is necessary to rapidly find the drug-candidates that can be used to treat the infection. Since the main protease (M(pro)) is the key protein in the virus's life cycle, M(pro) is served as one of the critical targets of anti...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801185/ https://www.ncbi.nlm.nih.gov/pubmed/33457495 http://dx.doi.org/10.1016/j.imu.2021.100516 |